Elbit Medical Technologies Ltd (EMTC-M.TA)
ILA 17.3
(0.0%)
ILA 17.3
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -51.47 Million USD | -6358.09% |
| 2022 | -797 Thousand USD | 85.83% |
| 2021 | -5.62 Million USD | -22.98% |
| 2020 | -4.57 Million USD | 80.23% |
| 2019 | -23.13 Million USD | -186.12% |
| 2018 | 26.86 Million USD | 534.13% |
| 2017 | -6.18 Million USD | 60.25% |
| 2016 | -15.56 Million USD | -17.47% |
| 2015 | -13.25 Million USD | -52.01% |
| 2014 | -8.71 Million USD | -26.24% |
| 2013 | -6.9 Million USD | -401.09% |
| 2012 | -1.37 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -127.5 Thousand USD | 0.0% |
| 2024 Q1 | -127.5 Thousand USD | 99.5% |
| 2023 Q4 | -25.6 Million USD | -568888.89% |
| 2023 FY | -271 Thousand USD | 66.0% |
| 2023 Q1 | -131 Thousand USD | -18.55% |
| 2023 Q2 | -131 Thousand USD | 0.0% |
| 2023 Q3 | -4500.00 USD | 96.56% |
| 2022 Q4 | -110.5 Thousand USD | 0.0% |
| 2022 FY | -797 Thousand USD | 85.83% |
| 2022 Q3 | -110.5 Thousand USD | 34.03% |
| 2022 Q2 | -167.5 Thousand USD | 0.0% |
| 2022 Q1 | -167.5 Thousand USD | -39.0% |
| 2021 Q1 | -1.37 Million USD | 62.75% |
| 2021 Q4 | -120.5 Thousand USD | 0.0% |
| 2021 Q2 | -1.88 Million USD | -37.35% |
| 2021 Q3 | -120.5 Thousand USD | 93.6% |
| 2021 FY | -5.62 Million USD | -22.98% |
| 2020 FY | -4.57 Million USD | 80.23% |
| 2020 Q1 | -527 Thousand USD | -128.36% |
| 2020 Q4 | -3.68 Million USD | -1402.45% |
| 2020 Q3 | -245 Thousand USD | 92.85% |
| 2020 Q2 | -3.42 Million USD | -550.47% |
| 2019 Q4 | 1.85 Million USD | 111.95% |
| 2019 Q1 | -467 Thousand USD | -102.04% |
| 2019 Q2 | -8.98 Million USD | -1823.13% |
| 2019 Q3 | -15.54 Million USD | -73.08% |
| 2019 FY | -23.13 Million USD | -186.12% |
| 2018 FY | 26.86 Million USD | 534.13% |
| 2018 Q4 | 22.86 Million USD | 1405.53% |
| 2018 Q3 | 1.51 Million USD | -73.39% |
| 2018 Q2 | 5.7 Million USD | 983.3% |
| 2018 Q1 | 527 Thousand USD | 423.31% |
| 2017 Q3 | -163 Thousand USD | 7.12% |
| 2017 Q1 | -175.5 Thousand USD | 96.9% |
| 2017 Q2 | -175.5 Thousand USD | 0.0% |
| 2017 FY | -6.18 Million USD | 60.25% |
| 2017 Q4 | -163 Thousand USD | 0.0% |
| 2016 Q1 | -3.69 Million USD | -138.96% |
| 2016 Q3 | -2.58 Million USD | 29.08% |
| 2016 Q2 | -3.63 Million USD | 1.46% |
| 2016 Q4 | -5.65 Million USD | -119.22% |
| 2016 FY | -15.56 Million USD | -17.47% |
| 2015 Q3 | -126 Thousand USD | 96.7% |
| 2015 Q1 | -4.53 Million USD | -1078.44% |
| 2015 Q4 | -1.54 Million USD | -1126.19% |
| 2015 Q2 | -3.81 Million USD | 15.89% |
| 2015 FY | -13.25 Million USD | -52.01% |
| 2014 Q2 | -214 Thousand USD | -5.42% |
| 2014 Q4 | -385 Thousand USD | -65.24% |
| 2014 Q3 | -233 Thousand USD | -8.88% |
| 2014 Q1 | -203 Thousand USD | 11.35% |
| 2014 FY | -8.71 Million USD | -26.24% |
| 2013 Q2 | -187 Thousand USD | 18.34% |
| 2013 FY | -6.9 Million USD | -401.09% |
| 2013 Q4 | -229 Thousand USD | -4.09% |
| 2013 Q3 | -220 Thousand USD | -17.65% |
| 2013 Q1 | -229 Thousand USD | 0.0% |
| 2012 FY | -1.37 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|